Millennium Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-413,400
Closed -$413K 6853
2023
Q3
$413K Sell
413,400
-147,301
-26% -$113K ﹤0.01% 4763
2023
Q2
$275K Buy
560,701
+88,821
+19% +$72.7K ﹤0.01% 4950
2023
Q1
$547K Sell
471,880
-664,381
-58% -$1.21M ﹤0.01% 4545
2022
Q4
$3.04M Buy
1,136,261
+1,050,046
+1,218% +$2.77M ﹤0.01% 3209
2022
Q3
$247K Buy
+86,215
New +$367K ﹤0.01% 5513
2022
Q1
Sell
-857,502
Closed -$15.6M 7770
2021
Q4
$15.6M Buy
857,502
+302,304
+54% +$6.52M 0.01% 1682
2021
Q3
$10.9M Buy
555,198
+487,092
+715% +$18.5M 0.01% 1948
2021
Q2
$3.05M Sell
68,106
-307,521
-82% -$14.3M ﹤0.01% 3413
2021
Q1
$18.9M Buy
375,627
+365,590
+3,642% +$24.9M 0.01% 1139
2020
Q4
$897K Buy
+10,037
New +$844K ﹤0.01% 3804

Millennium Management's CELL Position: Q4 2023 in Review

Millennium Management sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 413,400 shares — an estimated $413K sold.

Millennium Management first reported a position in CELL in Q4 2020 and held it in 10 quarters. The position peaked at $18.9M in Q1 2021. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

  • Millennium Management reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Millennium Management sold 413,400 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $413K.
  • Millennium Management first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 10 quarters.
  • Millennium Management's PhenomeX Inc. Common Stock position peaked at $18.9M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.